Alcresta Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
130 Turner St Bldg 3 Ste 200, Waltham, M...Website
www.alcresta.comRevenue
$21.6 MillionIndustry
About Alcresta Therapeutics
Alcresta Therapeutics specializes in enzyme-based products aimed at improving enteral nutrition for patients suffering from fat malabsorption due to rare diseases. Their flagship product, RELiZORB, utilizes patented microbead/enzyme technology to enhance fat digestion and absorption for individuals on enteral feeding. The company primarily serves patients with serious medical conditions, including cystic fibrosis and pancreatitis, who require nutritional support. Alcresta is committed to advancing clinical research and improving health outcomes for these patients.Explore more
SIC Code 28,283NAICS Code 32,325Show moreAlcresta Therapeutics Org Chart
Compare Similar Companies to Alcresta Therapeutics
Compare insights from companies similar to Alcresta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$21.9M
51-200
Private
-
1992
ML
Michael LyttonGroup Executive VP-Corp Development and Strategy and Gen Manager
Alcresta Therapeutics Tech Stack
A closer look at the technologies used by Alcresta Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Alcresta Therapeutics
Sign Up For FreeTo access detailed company insights
Alcresta Therapeutics specializes in enzyme-based products aimed at improving enteral nutrition for patients suffering from fat malabsorption due to rare diseases. Their flagship product, RELiZORB, utilizes patented microbead/enzyme technology to enhance fat digestion and absorption for individuals on enteral feeding. The company primarily serves p... Read More
